Discover
FBLG
FibroBiologics, Inc.
0.91
7 x 1.00
1 x 1.01
bid
ask
-
0.04
4.37%
4 @ 04:00 PM
0.93 +0.03 (2.99%)
| Ytd | -79.86% | |
| 1y | -92.46% |
0.90
day range
0.98
0.73
52 week range
14.68
| Open | 0.94 | Prev Close | 0.95 | Low | 0.90 | High | 0.98 | Mkt Cap | 4.72M |
| Vol | 105.86K | Avg Vol | 271.58K | EPS | -7.02 | P/E | N/A | Forward P/E | -5.83 |
| Beta | N/A | Short Ratio | 13.56 | Inst. Own | 15.83% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.09 | 200-d Avg | 5.09 | 1yr Est | 12.75 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.08 | -0.08 | N/A | N/A |
| 2024-08-07 | 2024-06 | -0.09 | N/A | N/A | N/A |
| 2024-08-07 | 2024-06 | -0.09 | -0.09 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-12-12 | Rodman & Renshaw | Upgrade | Buy | |
| 2024-11-20 | D. Boral Capital | Upgrade | Buy | Buy |
| 2024-11-13 | D. Boral Capital | Upgrade | Buy | Buy |
| 2024-11-13 | HC Wainwright & Co. | Upgrade | Buy | Buy |
| 2024-10-30 | HC Wainwright & Co. | Upgrade | Buy | |
| 2024-10-18 | EF Hutton | Upgrade | Buy | Buy |
Profile
FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. It holds 150+ U.S. and internationally issued patents/patents pending across various clinical pathways, including disc degeneration, orthopedics, multiple sclerosis, psoriasis, wound healing, reversing organ involution, and cancer. FibroBiologics, Inc. was incorporated in 2021 and is based in Houston, Texas.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-08-11 | KHOJA HAMID | Officer | 11.25K | Purchase |
| 2024-12-08 | O'HEERON PETER | Chief Executive Officer | 5.91M | Stock Gift |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Blackrock Inc. | 1.76M | 3.69M | 5.07% |
| 2024-09-29 | Vanguard Group Inc | 771.44K | 1.62M | 2.23% |
| 2024-09-29 | Geode Capital Management, LLC | 599.76K | 1.26M | 1.73% |
| 2024-09-29 | State Street Corporation | 475.84K | 999.26K | 1.37% |
| 2024-09-29 | Cascade Financial Partners, LLC | 302.60K | 635.46K | 0.87% |
| 2024-09-29 | Northern Trust Corporation | 210.47K | 441.99K | 0.61% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | iShares Russell 2000 ETF | 627.68K | 1.32M | 1.81% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 407.67K | 856.12K | 1.18% |
| 2024-08-30 | Fidelity Small Cap Index Fund | 259.50K | 544.95K | 0.75% |
| 2024-10-30 | iShares Russell 2000 Growth ETF | 259.30K | 544.52K | 0.75% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 152.81K | 320.89K | 0.44% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 142.80K | 299.88K | 0.41% |
Split
| Split | Date |
|---|---|
| 1 : 20 | 2026-03-30 |